Brief: InspireMD Announces Completion Of Enrollment In C-Guardians U.S. Investigational Device Exemption Clinical Trial
26/06/2023 13:30
June 26 (Reuters) - InspireMD Inc NSPR.O :
* INSPIREMD ANNOUNCES COMPLETION OF ENROLLMENT IN
C-GUARDIANS U.S.
INVESTIGATIONAL DEVICE EXEMPTION (IDE) CLINICAL TRIAL
* INSPIREMD INC - ANTICIPATES STUDY RESULTS AND PREMARKET
APPROVAL
(PMA) SUBMISSION IN H2 2024, POTENTIAL U.S. APPROVAL IN H1 2025
Source text for Eikon: ID:nGNX9qDmbh
Further company coverage: NSPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InspireMD
See all newsInspireMD Inc reports results for the quarter ended June 30 - Earnings Summary
InspireMD Q2 revenue beats estimates on international demand
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Q1 revenue jumps 122%, beats estimates on product demand